A renal biopsy study of hepatitis B virus-associated nephropathy in Korea  by Lee, Hyun Soon et al.
Kidney International, Vol. 34 (1988), PP. 537—543
A renal biopsy study of hepatitis B virus-associated nephropathy
in Korea
HYUN SOON LEE, YONG CH0!, SUK HEE Yu, HAENG IL KOH, MYUNG JAE KIM,
and KWANG WooK Ko
Departments of Pathology and Pediatrics, College of Medicine, Seoul National University, Chong-No Ku, Yun Keun Dong 28; Department of
Internal Medicine, College of Medicine, Chung-Ang University; Department of Internal Medicine, Paik Hospital, Inje Medical College; and
Department of Internal Medicine, College of Medicine, Kyung-Hee University, Seoul, Korea
A renal biopsy study of hepatitis B virus-associated nephropathy in
Korea. The pathogenic role of the hepatitis B virus (HBV) infection for
glomerulonephritis (GN) is not clear. The frequency of HB5Ag has been
studied in sera of 732 consecutive patients who have glomerular
diseases by using radioimmunoassay. The frequency of HBs anti-
genemia was 11.9%, which was not different from that in the general
population of South Korea. Of the 87 HB5Ag seropositive patients with
GN, 29 cases with membranoproliferative GN (MPGN) and eighteen
with membranous nephropathy (MN) were diagnosed as having HBV-
associated nephropathy. Eighty-seven and one-half percent of the
adults with MPGN and 80% of the children with MN were HBsAg
carriers. The morphologic findings and laboratory data in cases with
HBV-associated MPGN and MN did not differ significantly from those
observed in patients with MPGN and MN without circulating HBsAg.
Yet mesangial deposits were more frequently noted in patients with
HBV-associated MN when compared to others with idiopathic MN.
Glomerular deposits of HBsAg were not detected using indirect immu-
nofluorescence technique. Even though HB5Ag was not demonstrable
within the glomeruli, HBV infection seems to play an important role in
the pathogenesis of MPGN in Korean adults and MN in children.
The geographical distribution of hepatitis B virus (HBV)
infection varies considerably ranging from 0.1% in parts of
Western Europe, North America and Australia to 20% or even
higher in some populations of Asian, African and Western
Pacific countries [1]. HBV infection has been involved in
several forms of immune-related glomerulopathy, such as mem-
branous nephropathy (MN) and membranoproliferative glomer-
ulonephritis (MPGN). Since Combes et a! [21 first reported the
association of persistent Australia antigenemia and MN, many
attempts have been made to define the morphological and
clinical characteristics of HBV-associated nephropathy and to
demonstrate antigenic material within the glomeruli of patients.
Hepatitis B surface antigen (HBsAg) has been most often the
only antigen studied in the serum as well as in the glomerular
deposits. Although a number of authors [2—16] reported that
HBsAg was stained by direct or indirect fluorescent antibody
technique, the others [17—23] could not confirm the observation.
Furthermore, the presence of HBsAg was demonstrated in the
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glomeruli of patients who had no detectable HBsAg in the
serum [4, 8, 10, 12, 24, 25]. Such conflicting results made some
researchers doubt the specificity of fluorescent staining for
HBsAg within the deposits [10, 24, 26, 27]. In addition, the
limited amounts of information, gained mostly from studies on
children, have precluded characterization of the clinical and
pathological features of HBV-associated nephropathy.
In South Korea where HBV infection is particularly preva-
lent, with a frequency of HBsAg carriers as high as 10 to 15%
[28], the percentage of patients with both glomerular disease
and circulating HBsAg is also high. In this paper, we attempt to
examine the frequency of HBs antigenemia in patients with
glomerular diseases and to describe morphological and clinical
features of HBV-associated nephropathy.
Methods
Patients
A total of 732 consecutive patients with glomerular diseases
was evaluated at the Department of Pathology, Seoul National
University during the 30 month period ending in October 1987.
Five hundred and sixty patients were adults and 172 were
children. All of the specimens were from patients residing in
South Korea referred from hospitals throughout the country.
The circulating HBsAg and antibody (anti-HBs), hepatitis B e
antigen (HBeAg) and antibody (anti-HBe), and anti-hepatitis B
core antibody (anti-HBc) were screened by radioimmunoassay
(RIA; kits AUSRIA II, AUSAB, ABBOTT-HBe, CORAB,
Abbott Lab., Chicago, Illinois, USA). For each patient data
were collected concerning age, sex, date of clinical onset, blood
pressure, routine renal and liver function tests, plasma protein,
antistreptolysin-o titer, LE cells, anti-DNA antibodies, antinu-
clear factor, complement C3, complement C4, complement
hemolytic activity CH5O, urinalysis and 24-hour urinary protein
quantitation.
Pathological study
Renal biopsies, all of which contained at least six glomeruli,
were processed for light, electron and immunofluorescent mi-
croscopy using standard methodologies previously described
[29].
Light- and electron microscopy. Biopsy specimens for light
microscopy were fixed in Zenker's fixative, embedded in
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Table 1. Renal histopathology and circulating hepatitis B surface antigen (HBsAg) in patients with glomerular lesions
Diagnosis
Number examined Number of HBsAg carriers
Adults Children TotalAdults Children Total
Epithelial cell disease
Focal segmental glomerulosclerosis
Membranous nephropathy
Membranoproliferative ON
IgAnephropathy
Postinfcctious ON
Mild focal nonspecific ON
Diffuse sclerosing ON
Systemic lupus erythematosus
Henoch-Schonlein nephritis
Miscellaneous
92
48
49
32
192
21
41
12
51
10
12
48
22
10
4
22
22
20
3
5
13
3
140
70
59
36
214
43
61
15
56
23
15
3
3
10
28
IS
2
3
2
—
—
—
3
3
8
1
I
2
2
—
I
—
—
6
6
18
29
16
4
5
2
I
—
—
560 172 732 66 21 87
Abbreviation is: ON, glomerulonephritis.
paraffin, serially sectioned and stained with hematoxylin and
eosin, and periodic acid-Schiff (PAS). For electron microscopy,
renal tissue was fixed in osmic acid and embedded in epoxy-
resin. Ultrathin sections were stained with uranyl acetate and
lead citrate prior to examination. Electron dense deposits were
evaluated according to their location: mesangial, subendo-
thelial, subepithelial, or intramembranous.
Immunofluorescence. Direct immunofluorescence method
was used with fluoresceinated monospecific antisera to human
IgG, 1gM, IgA, C3 and fibrinogen purchased from Dako Cor-
poration (Santa Barbara, California, USA). The amount of
fluorescence was graded —, 1+, 2+, 3+, 4+.
Indirect immunofluorescence testing was carried out for
HBsAg using the rabbit anti-HBs reagents as the primary
antibody. The anti-HBs sera were made two times: the first
batch was prepared from No. 1 rabbit immunized with purified
HBsAg (Green Cross Corp., Yongin, Korea). The second one
was separately made from No. 2 and 3 rabbits two and a half
years later, using the HBsAg from the same company. The
positivity for anti-HBs was checked by RIA and its titer was
expressed in RIA units. The second reagent was FITC-labeled,
swine anti-rabbit immunoglobulins (Dako Corp.). For negative
control studies, frozen sections of kidney from seven cases of
idiopathic MN and ten cases of diffuse proliferative lupus
nephropathy were used. There was a positive reaction when the
antisera from No. 1 rabbit were used as the first reagent,
whereas no reactivity was observed when the primary antibody
from No. 2 and 3 rabbits and FITC-labeled antibody were used
in sequence or when the FITC-labeled antibodies were used
alone. Therefore, for our study only antibodies from No. 2 and
3 rabbits were employed as the primary reagent. Frozen liver
sections of three patients known to contain cytoplasmic HBsAg
served as positive controls; many hepatocytes showed cyto-
plasmic staining, following the indirect immunolluorescence
procedure with the rabbit anti-FIBs preparation as the first
reagent and FITC-labeled anti-rabbit IgG or FITC-labeled anti-
rabbit IgO F(ab')2 (Cappel Lab.) as the second reagent (Fig. 1).
Results
Eighty-seven of the 732 patients with glomerular lesions were
HBsAg carriers: 66 patients (11.8%) out of 560 adults and 21
(12,2%) out of 172 children had seropositivity (Table 1). Forty
Fig. 1. Numerous hepatocytes containing HBsAg in their cytoplasm
detected by indirect immunofluorescence, x 350
of the 87 EBsAg positive patients were excluded from the group
of HBV-associated nephropathy: six had epithelial cell disease,
six focal segmental glomerulosclerosis, sixteen IgA nephrop-
athy (IgA N), four postinfectious glomerulonephritis (ON), five
mild focal nonspecific ON, two diffuse sclerosing GN, and one
showed membranous lupus nephropathy. Twenty-nine HBsAg
carriers with MPGN and 18 seropositive patients with MN were
diagnosed as having HBV-associated nephropathy, and these
patients formed the basis of this study.
HB V-associated membranoproliferative glomerulonephritis
Clinical features at the time of biopsy. Of the 29 patients,
only one was a child (Table 2). There was a preponderance of
males in the 28 adults, who had a mean age of 30 years. In
fifteen patients HBsAg carriage was detected at the time of
renal biopsy when one to 15 years had elapsed since the onset
of renal disease, while the development of renal abnormalities
coincided with the discovery of FIBs antigenemia in 12. Only
two patients had known HBs antigenemia or chronic liver
disease ten months to three years earlier than the onset of renal
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Table 2. Clinical data in patients with hepatitis B virus-associated
membranoproliferative glomerulonephritis (MPGN) and membranous
nephropathy (MN) at time of biopsy
MPGN MN
Adults Child Adults Children
N=28 N=l N=lO N=8
Age years 30.3 7.3 13 40.2 10.5 7.4 4.3
Range 16—45 23—50 2—14
SexM:F 23:5 0:1 9:1 5:3
Mean duration of disease
before biopsy months 31.1 5 14.7 2.8
Range 0.5—180 0.2—54 0.5—9
Serum
HBsAg+ 28/28 (100) 1 10/10 (100) 8/8 (100)
HBeAg+ 16/19 (84) 1 6/9 (67) 6/6 (100)
Anti-HBs+ 1/27 (4) 0 2/9 (22) 0/8
Anti-HBe+ 1/14 (7) ND 2/7 (29) 0/4
Anti-HBc+ 23/24 (96) 1 8/8 (100) 6/6 (100)
Hypertension 13/28 (46) 0 1/10 (tO) 0/8
Renal impairment 6/28 (21) 0 1/10 (10) 0/8
Proteinuria g/24 hr
<1.0 5/28 (18) 0 0 3/8 (38)
1.0—3.4 8/28 (28) I 3/10 (30) 3/8 (38)
3.5 15/28 (54) 0 7/10 (70) 2/8 (25)
Hematuria 21/28 (75) 1 4/10 (40) 8/8 (100)
Hypocomplementemia 11/26 (42) 1 2/10 (20) 4/7 (57)
Increased SGOT/SGPT 18/28 (64) I 5/10 (50) 5/8 (63)
Table 3. Ultrastructural features in patients with HBV-associated
membranoproliferative glomerulonephritis (MPGN) and membranous
nephropathy (MN)
Number of positive cases
Subendothelial Subepithelial Mesangial
deposits deposits deposits
HBV-associated
MPGN (N = 28) 28 22 28
HBV-associated
MN(N= 17) 4 17 12
disease. No patients showed signs of systemic lupus erythema-
tosus (SLE). All the patients' sera were positive for HBsAg.
Eighty-five percent of the 20 patients showed positive HBeAg,
while the positivity for anti-HBs or anti-HBe was less than 8%,
respectively. Hypertension, defined as blood pressure greater
than 140/90 mm Hg, was present in 13 patients (44.8%). Renal
insufficiency, diagnosed as serum creatinine in excess of 1.5
mgi'dl, was noted in six patients (20.7%), mostly in mild degree;
of the five patients who were followed from six months to two
years two revealed the restoration of normal renal function at
their last examination, whereas three exhibited persistently and
slightly abnormal renal function. Proteinuria was observed in
all, ranging from 0.6 to 19 glday, and fifteen (5 1.7%) had
nephrotic range proteinuria  3.5 g per day. One patient
presented gross hematuria. Microscopic hematuria greater than
5 RBC per hpf was noted in 21(72.4%). The serum complement
C3 and/or C4 values were decreased in twelve patients (44.4%).
Nineteen patients (65.5%) showed increased serum transami-
nase levels.
Pathological features. In all 29 patients, glomerular lobula-
HBV-associated
MPGN (N = 24) 17 23 12 13 7 0(11)
HBV-associated
MN (N = 16) 16 13 2 14 5 0 (6)
Figures in parentheses refer to the number of patients in whom these
tests were done.
Fig. 2. Hepatitis B virus-associated membranoprolferative GN show-
ing prominent increase in mesangial substance and localized thickening
of peripheral capillary loops. PAS stained; x 430
tion, mesangial sclerosis and hypercellularity, and thickening of
peripheral capillary loops were present in great variability
(Figs. 2 and 3). Segmental or global sclerosis was observed in 25
patients. Small crescents were rarely noted. One case showed
segmental aneurysmal dilatation of capillary walls. Minimal to
marked tubulointerstitial change was present in all. Ultrastruc-
turally, there were massive circumferential subendothelial de-
posits and moderate to heavy mesangial deposits in all 28
patients studied, with subepithelial and/or intramembranous
deposits in 22 (Table 3, Fig. 4). One patient had subepithelial
deposits, resembling humps. Mesangial interposition affected
stretches of the capillary walls in all biopsy specimens, and was
occasionally circumferential. In some interposed mesangium,
the deposits showed severe resolution. Microtubular myxovi-
rus-like structures were present in glomerular endothelial cells
in five patients. Of the 24 patients with immunofluorescent
staining, 17 disclosed granular, usually confluent deposition of
IgG in peripheral portions of glomerular capillary loops (Table
4). Twenty-three showed 1gM deposition. IgA staining was
noted in 12 and C3 in 13. Immunofluorescence for HBsAg was
Table 4. Results of immunofluorescence microscopy
Number of positive cases
IgG 1gM IgA C3 Fibrinogen HBsAg
done.
Figures in parentheses refer to percentage of positives. ND, not
•f tS4r.P S ,a
-'S • I
<1 •I
p
'lb
.e.src.. .,t',S
. 0S
540 Lee et al: Hepatitis B virus-associated nephropathy
Fig. 3. Hepatitis B virus-associated membranoproliferative GN show-
ing considerably thickened capillary loops due to mesangial interposi-
tion and clumpy subendothelial deposits. H&E stained; x 400
negative in all eleven cases studied. Liver biopsy was per-
formed in five patients and showed macronodular cirrhosis in
one patient and chronic aggressive hepatitis in four.
HB V-associated membranous nephropathy
Clinicalfeatures at the time of biopsy. Of the 18 patients with
HBV-associated MN, eight were 14 years or younger. Clinical
data at the time of the biopsy are summarized in Table 2, in
which patients are grouped according to the age. Male predom-
inance was only noted in adult group. Most patients were
edematous at onset of the disease, whereas in two the presence
of renal disease was found through the urinary examination in
school children. Although not statistically significant, the mean
duration of disease before biopsy was shorter in children. HBs
antigenemia was frequently detected by systematic investiga-
tion for the diagnostic work-up of renal disease, whereas in two
cases it preceded the onset of ON. None of the patients had
clinical or laboratory evidence of SLE. All of the patients' sera
were positive for HBsAg and anti-HBc. Eighty percent of the
patients tested showed positive HBeAg. Hypertension was
observed only in one patient and so was the case with border-
line increase in serum creatinine concentration. Proteinuria was
noted in all ranging from 0.4 to 10 g/day, the amount of which
was significantly larger in adult group when compared to that in
children (P c 0.02). No patients presented gross hematuria.
Microscopic hematuria was found in all of the children and 40%
of the adults; the frequency of hematuria in children was
significantly higher than that in adults (P < 0.02). There were
35.3% of the patients who had low or borderline low C3 and/or
C4 level. In ten patients serum transaminase levels were
elevated.
Fig. 4. Electron micrograph from hepatitis B virus-associated mem-
branoproliferative GN showing large subendothelial deposits (d) incor-
porated into mesangial matrix (M) as with moderate amounts of
intramembranous and meson gial deposits. E = endothelial cell nu-
cleus. x 6,500
Pathological features (Tables 3 and 4). In all 18 patients the
renal biopsy by light microscopy showed diffuse thickening of
the capillary walls. Nine cases exhibited mild to moderate
mesangial cell proliferation with or without increase in matrix
(Fig. 5). Ultrastructural studies were performed in 17 patients,
showing diffuse glomerular subepithelial and/or intramembran-
ous deposits in all patients and small amounts of mesangial
deposits in twelve. In addition, a few isolated tiny subendo-
thelial deposits were noted in four biopsy specimens (Fig. 6).
The lesions were classified according to the criteria of
Ehrenreich and Churg [301: stage I was observed in four
patients, II in eleven, III in one, and IV in one. The glomerular
changes were not uniform in the same biopsy specimen, and
were graded on the basis of the morphology of the majority of
capillary loops observed. Microtubular virus-like structures in
glomerular endothelial cells were found in four patients. Immu-
nofluorescence studies revealed diffuse coarsely granular stain-
ing of IgG along the glomerular capillary wall of all 16 biopsy
specimens, with lesser amounts of 1gM in 13, IgA in two, and
C3 in 14. HBsAg was negative in all six specimens tested. Liver
biopsy was performed in one patient showing chronic aggres-
sive hepatitis.
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Fig. 5. Hepatitis B virus-associated membranous nephropathy show-
ing uniformly thickened capillary walls with mild increase in cellularity.
H&E stained; x 400
Discussion
In this study, we examined the frequency of HBsAg
seropositivity in various forms of glomerular diseases and also
investigated several clinical and pathological features of Korean
patients who had HBV-associated nephropathy.
The frequency of HBs antigenemia in the patients with
glomerular diseases, either primary or secondary, was 11.9%,
showing no difference between adults and children. The HBsAg
carrier rate of 11.9% is not different from 10 to 15% in the
general population of South Korea including both adults and
children. In contrast, several authors [8, 12, 24, 31—34] reported
it was significantly greater among the patients with GN when
compared to that in the general population or in hospital
patients, suggesting that HBsAg carriers were predisposed to
renal disease. Such a divergence of findings may be due to
differences in case selection, methods of detection of markers
of HBV, or geographic distribution.
Most of the previous reports [10, 14, 17, 19, 21, 33] empha-
sized the strikingly high incidence of MN associated with HBV
occurring mainly in children. Although the number is small,
eight (80%) out of ten children with MN in our series had
HBsAg seropositivity partly supporting these notions. Never-
theless, the correlation between HBs antigenemia and MPGN
in adults of our series was remarkable: 87.5% of the adults with
MPGN were HBsAg carriers. This strong association of chronic
HBs antigenemia and MPGN in adults has never been empha-
sized before and needs further confirmation, particularly in the
regions having a high frequency of HBsAg carriers. The reasons
for the different morphological predilection between adults and
children are not evident, although some variations in immune
responsiveness to the diverse HBV antigens could play a role.
Excluding the cases of HBV-associated MPGN in our series
the frequency of idiopathic MPGN among primary glomerular
diseases was less than 1.1%. The result is interesting in view of
the recent reports that MPGN is disappearing in some Euro-
pean countries, which is speculated to be related to the de-
creased incidence of bacterial infections [35, 36]. The probable
role of HBV for the pathogenesis of MPGN likewise suggests
that through the control of this viral infection the frequency of
MPGN may be markedly reduced, especially in the countries
with a high prevalence of HBV carriers.
Several cases with IgA N related to HBsAg were reported [8,
11, 34]. However, the association between HBV infection and
IgA N in this study is weak and may be incidental in view of the
low frequency of HBsAg carriage in patients with IgA N, as
were the cases with nonimmune-related glomerular diseases.
The morphological features showed no characteristic pattern
in HBV-associated MPGN when compared to other patients
with variable stages of MPGN type I without circulating HBsAg
[37]. Those of HBV-associated MN were also indistinguishable
from the cases with idiopathic MN, except for the frequent
occurrence of small mesangial deposits with or without suben-
dothelial deposits in the former, as has already been noted by
some authors [23, 38].
There seems to be a striking male predominance in our adult
patients with both forms of HBV-associated GN. However, we
could not confirm the previous reports [10, 17, 19, 23, 33, 38] of
a male preponderance in our pediatric cases.
Although the frequency of hypocomplementemia appears to
be higher in adults with HBV-associated MPGN and children
with HBV-associated MN when compared to that in adults with
HBV-associated MN, the difference was not statistically signif-
icant. Previous reports of a relationship between hypocomple-
mentemia and HBV-associated MN are not conclusive:
Kleinknecht et al [19] believed the disturbances in serum
complement levels were no more specific, whereas others [21,
23, 33, 38] regarded them as characteristic clinical features. In
one-third of our patients with forms of MN, serum C3 or C4
values tended to be low. However, in the cases with HBV-
-
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associated MPGN the frequency of hypocomplementemia was
rather low when compared to that of idiopathic MPGN, sug-
gesting hypocomplementemia in HBV-associated nephropathy
is nonspecific.
Using indirect immunofluorescence technique we could not
detect HBsAg in the glomeruli of our 17 patients with HBV-
associated ON. As mentioned above, the results on HBsAg
staining in glomeruli have been discordant. Various authors
have all used their own antisera against HBsAg with direct or
indirect immunofluorescence techniques. There appears to be a
considerable difference in these antibodies as already shown by
testing of our own reagents, and this may partially explain the
marked differences in the results on HBsAg staining.
Even though HBsAg deposition was not demonstrable within
the glomeruli, the etiologic role of HBV infection in MPGN or
MN cannot be excluded. Several authors from Japan and the
United States [18, 20, 22, 23, 27] have recently claimed that
HBV-associated nephropathy may be mainly mediated by
HBeAg. We also examined the presence otglomerular HBV
antigens in three new cases with HBV-associated MPGN or
MN using FITC-labeled F(ab')2 fragments of monoclonal anti-
HBs, anti-HBc and anti-HBe; glomerular HBeAg staining was
noted in a patient with HBV-associated MN, while neither
HBsAg nor HBcAg was seen in all of the three cases tested
(unpublished data). Our demonstration of HBeAg supports the
view of those Japanese authors [18, 20, 22, 23] that HBeAg is
actually present in the glomerular deposits of patients with
HBV-associated MN. Yet the possible responsibility of the
different HBV antigens for the pathogenesis of ON needs
further thorough investigation.
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